Scientific Advisory Board

The SAB has an advisory role and will address the scientific and strategic developments of CBCS from an international perspective. The members of the scientific advisory board should be internationally recognised researchers in chemical biology with extensive experience from international organisations or infrastructures within the field. The SAB should meet once a year with representatives from the CBCS board and organisation to evaluate and challenge the CBCS activities and strategy.

The first SAB meeting is planned to take place in June 2012 at Karolinska Institutet.

Members of the SAB for 2012 are:

Professor Stephen V. Frye (Division of Medicinal Chemistry and Natural Products, and Director, Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina at Chapel Hill, US)

Professor Herbert Waldmann (Director, Dept. Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany)

Dr. James Inglese (Group Leader, Assay Technology Development, National Human Genome Research Institute/NIH, Bethesda, US)